Ritholtz Wealth Management bought a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 19,650 shares of the company’s stock, valued at approximately $1,285,000.
A number of other large investors have also recently bought and sold shares of the stock. Joel Isaacson & Co. LLC acquired a new position in shares of GE HealthCare Technologies in the third quarter worth $207,000. Jacobi Capital Management LLC acquired a new stake in shares of GE HealthCare Technologies during the third quarter valued at $52,000. Jefferies Financial Group Inc. boosted its stake in shares of GE HealthCare Technologies by 56.1% during the third quarter. Jefferies Financial Group Inc. now owns 371,013 shares of the company’s stock valued at $24,253,000 after acquiring an additional 133,360 shares during the last quarter. First Command Advisory Services Inc. increased its position in GE HealthCare Technologies by 226.1% during the 3rd quarter. First Command Advisory Services Inc. now owns 1,784 shares of the company’s stock worth $117,000 after purchasing an additional 1,237 shares in the last quarter. Finally, Northbridge Financial Group LLC increased its position in GE HealthCare Technologies by 15.5% during the 3rd quarter. Northbridge Financial Group LLC now owns 8,446 shares of the company’s stock worth $547,000 after purchasing an additional 1,132 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.
GE HealthCare Technologies Price Performance
GEHC stock opened at $82.96 on Tuesday. GE HealthCare Technologies Inc. has a 52-week low of $58.75 and a 52-week high of $89.77. The stock’s fifty day simple moving average is $70.83 and its 200-day simple moving average is $70.13. The company has a quick ratio of 1.01, a current ratio of 1.30 and a debt-to-equity ratio of 0.86. The stock has a market capitalization of $37.51 billion, a price-to-earnings ratio of 17.50, a price-to-earnings-growth ratio of 2.06 and a beta of 0.65.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last announced its quarterly earnings data on Wednesday, October 28th. The company reported $1.34 EPS for the quarter, beating analysts’ consensus estimates of $1.20 by $0.14. The business had revenue of $5.51 billion during the quarter, compared to the consensus estimate of $5.35 billion. GE HealthCare Technologies had a return on equity of 20.45% and a net margin of 9.96%. The business’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.07 earnings per share. Equities research analysts expect that GE HealthCare Technologies Inc. will post 5.02 EPS for the current year.
GE HealthCare Technologies Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, November 13th. Shareholders of record on Friday, October 23rd were paid a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend was Friday, October 23rd. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. GE HealthCare Technologies’s dividend payout ratio is 3.38%.
Analyst Ratings Changes
Several brokerages recently weighed in on GEHC. Piper Sandler reissued a “buy” rating on shares of GE HealthCare Technologies in a research note on Wednesday, July 29th. Wolfe Research started coverage on shares of GE HealthCare Technologies in a research note on Tuesday, October 20th. They set a “peer perform” rating on the stock. Barclays raised their price target on shares of GE HealthCare Technologies from $85.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, October 29th. JPMorgan Chase & Co. lifted their price target on shares of GE HealthCare Technologies from $70.00 to $80.00 and gave the stock a “neutral” rating in a report on Thursday, October 29th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $93.00 price objective on shares of GE HealthCare Technologies in a research report on Monday, October 5th. Twelve investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $82.17.
View Our Latest Stock Analysis on GEHC
GE HealthCare Technologies Company Profile
GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.
Featured Stories
- Five stocks we like better than GE HealthCare Technologies
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
